[Malignant hemopathies and tumor lysis syndrome: a current topic]

Arch Pediatr. 2005 Oct:12 Spec No 1:1-3.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antimetabolites / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Child
  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Recombinant Proteins
  • Tumor Lysis Syndrome / drug therapy
  • Tumor Lysis Syndrome / etiology*
  • Urate Oxidase / therapeutic use

Substances

  • Antimetabolites
  • Antineoplastic Agents
  • Recombinant Proteins
  • rasburicase
  • Urate Oxidase